Latest On Ocular Therapeutix, Inc (OCUL):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 23:34 EST | News | Ocular Therapeutix: I Still Don't See The Need | N/A |  |
| 2023-05-09 02:50 EST | News | Ocular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73M | N/A | |
| 2023-05-09 02:50 EST | News | Ocular Therapeutix, Inc. (OCUL) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 01:03 EST | News | Ocular Therapeutix Q1 2023 Earnings Preview | N/A | |
| 2023-03-07 22:48 EST | News | Ocular Therapeutix stock rises after posting Q4 results beat, strong guidance | N/A | |
| 2023-03-07 08:01 EST | News | Ocular Therapeutix, Inc. (OCUL) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-06 17:33 EST | News | Ocular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensus | N/A | |
| 2023-03-06 02:44 EST | News | Ocular Therapeutix Q4 2022 Earnings Preview | N/A | |
| 2023-03-04 00:55 EST | News | Ocular Therapeutix: A Promising Turnaround Play | N/A | |
| 2023-02-14 11:58 EST | News | Next Round Of Financing Will Be Transformational For Ocular Therapeutix | N/A | |
| 2023-02-13 09:49 EST | News | Ocular stock rises ~15% as eye drug implant shows promise in ongoing phase 1 trial | N/A | |
| 2023-02-12 21:43 EST | News | Ocular Therapeutix: A 'Buy' On Maturing Wet AMD Data | N/A | |
| 2022-12-12 00:53 EST | News | Ocular Therapeutix: Good Potential, But Not That Good An Execution | N/A | |
| 2022-11-08 16:55 EST | News | Ocular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlook | N/A | |
| 2022-11-08 16:55 EST | News | Ocular Therapeutix hits 52-week low after slashing revenue guidance | N/A | |
| 2022-11-07 22:46 EST | News | Ocular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3M | N/A | |
| 2022-11-07 22:46 EST | News | Ocular Therapeutix, Inc. (OCUL) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-07 06:22 EST | News | Ocular Therapeutix Q3 2022 Earnings Preview | N/A | |
| 2022-09-27 15:05 EST | News | Ocular stock rises as eye drug implant OTX-TKI shows promise in vision disorder in trial | N/A | |
| 2022-08-22 02:45 EST | News | Ocular Therapeutix: Dextenza Sales Accelerating And Near-Term Catalyst Approaching | N/A | |
| 2022-08-15 19:39 EST | News | Ocular Therapeutix:Â Trading Ahead Of An Underappreciated Catalyst Event | N/A | |
| 2022-08-09 06:07 EST | News | Ocular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99M | N/A | |
| 2022-08-09 06:07 EST | News | Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-08 05:34 EST | News | Ocular Therapeutix Q2 2022 Earnings Preview | N/A | |
| 2022-05-10 11:19 EST | News | Ocular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77M | N/A | |
| 2022-05-10 11:18 EST | News | Ocular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-07 05:46 EST | News | Ocular Therapeutix Q1 2022 Earnings Preview | N/A | |
| 2022-03-29 07:01 EST | News | Ocular Therapeutix: A Follow-Up | N/A | |
| 2022-03-08 17:48 EST | News | Ocular Therapeutix: Transformative Year Ahead Full Of Important Milestones | N/A | |
| 2022-03-01 10:49 EST | News | Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 16:33 EST | News | Ocular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13M | N/A | |
| 2022-02-27 21:16 EST | News | Ocular Therapeutix Q4 2021 Earnings Preview | N/A | |
| 2022-01-19 15:59 EST | News | Ocular Therapeutix owner buys 50,000 shares worth ~$300K | N/A | |
| 2022-01-19 00:54 EST | News | AffaMed Therapeutics begins dosing in China trial of DEXTENZA to treat ocular inflammation | N/A | |
| 2022-01-08 01:34 EST | News | Ocular Therapeutix: Shaken By Covid, Perfectly Positioned For Long-Term Gains | N/A | |
| 2021-12-12 09:46 EST | News | Highlighting Ocular Therapeutix | N/A | |
| 2021-12-10 00:37 EST | News | Ocular Therapeutix trades high on director acquiring 60.9K shares | N/A | |
| 2021-12-08 10:52 EST | News | Warning: OCUL is at high risk of performing badly | N/A | |
| 2021-12-06 20:03 EST | News | Ocular Therapeutix reports positive OTX-DED data in mid-stage dry eye disease study | N/A | |
| 2021-11-09 14:12 EST | News | Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-08 16:27 EST | News | Ocular Therapeutix EPS beats by $0.04, misses on revenue | N/A | |
| 2021-11-07 19:57 EST | News | Ocular Therapeutix Q3 2021 Earnings Preview | N/A | |
| 2021-10-24 05:07 EST | News | MeiraGTx, Aurinia among healthcare gainers this week; Jasper slips after twofold rise | N/A | |
| 2021-10-22 16:55 EST | News | Ocular Therapeutix posts topline results from mid-stage OTX-CSI dry eye disease trial | N/A | |
| 2021-10-11 15:36 EST | News | Ocular Therapeutix gains on FDA approval of DEXTENZA for new indication | N/A | |
| 2021-10-11 15:36 EST | News | Oyster Point benefits from Ocular sNDA approval; shares up 13% | N/A | |
| 2021-08-10 09:07 EST | News | Ocular Therapeutix EPS misses by $0.05, beats on revenue | N/A | |
| 2021-08-10 09:06 EST | News | Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-09 12:28 EST | News | Ocular Therapeutix: Why I'm Buying The Dip | N/A | |
| 2021-08-06 08:09 EST | News | Ocular Therapeutix and Regeneron scrap collaboration agreement | N/A | |
About Ocular Therapeutix, Inc (OCUL):
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
General
- Name Ocular Therapeutix, Inc
- Symbol OCUL
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 181
- Fiscal Year EndDecember
- IPO Date2014-07-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.ocutx.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 91.26
- Price/Book (Most Recent Quarter) 124.04
- Enterprise Value Revenue 87.16
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.69
- Next Year EPS Estimate -$0.25
- Next Quarter EPS Estimate -$0.17
- Operating Margin -361%
- Return on Assets -23%
- Return on Equity -430%
- Revenue 17.4 million
- Earnings Per Share -$1.79
- Revenue Per Share $0.29
- Gross Profit -13374000
- Quarterly Earnings Growth 225.8%
View More
Highlights
- Market Capitalization 1.55 billion
- EBITDA -71014000
- PE Ratio -9.94
- Analyst Target Price $25.5
- Book Value Per Share $1.00
View More
Share Statistics
- Shares Outstanding 76.07 million
- Shares Float 66.88 million
- % Held by Insiders 466%
- % Held by Institutions 55.42%
- Shares Short 5.07 million
- Shares Short Prior Month 4.75 million
- Short Ratio 4.88
- Short % of Float 8%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 2.19
- 52 Week High $24.3
- 52 Week Low $4.09
- 50 Day Moving Average 19.01
- 200 Day Moving Average 15.53
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Ocular Therapeutix, Inc (OCUL) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Ocular Therapeutix, Inc (OCUL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-11 | $7.35 million | -$0.23 | -$0.17 | -35.82% |
| 2020-09-30 | 2020-11-05 | $5.88 million | -$0.19 | -$0.25 | 22.98% |
| 2020-06-30 | 2020-08-07 | $N/A | -$0.64 | -$0.32 | -97.96% |
| 2020-03-31 | 2020-05-08 | $2.61 million | -$0.41 | -$0.50 | 17.17% |
| 2019-12-31 | 2020-03-12 | $2.26 million | -$0.53 | -$0.42 | -26.19% |
| 2019-09-30 | 2019-11-12 | $829000 | -$0.45 | -$0.46 | 2.17% |
| 2019-06-30 | 2019-08-07 | $650000 | -$0.57 | -$0.48 | -17.94% |
| 2019-03-31 | 2019-05-10 | $492000 | -$0.41 | -$0.42 | 1.2% |
| 2018-12-31 | 2019-03-07 | $504000 | -$0.42 | -$0.38 | -9.38% |
| 2018-09-30 | 2018-11-07 | $498000 | -$0.38 | -$0.37 | -2.7% |
| 2018-06-30 | 2018-08-07 | $648000 | -$0.37 | -$0.38 | 1.33% |
| 2018-03-31 | 2018-05-08 | $340000 | -$0.40 | -$0.41 | 2.44% |
| 2017-12-31 | 2018-03-08 | $487000 | -$0.44 | -$0.53 | 16.98% |
| 2017-09-30 | 2017-11-07 | $523000 | -$0.54 | -$0.53 | -1.89% |
| 2017-06-30 | 2017-08-08 | $438000 | -$0.64 | -$0.57 | -11.5% |
| 2017-03-31 | 2017-05-05 | $475000 | -$0.58 | -$0.48 | -20.01% |
| 2016-12-31 | 2017-03-10 | $511000 | -$0.52 | -$0.46 | -13.66% |
| 2016-09-30 | 2016-11-09 | $477000 | -$0.39 | -$0.50 | 21.61% |
| 2016-06-30 | 2016-08-09 | $441000 | -$0.46 | -$0.49 | 5.49% |
| 2016-03-31 | 2016-05-10 | $458000 | -$0.44 | -$0.43 | -1.95% |
| 2015-12-31 | 2016-03-10 | $436000 | -$0.43 | -$0.47 | 9.15% |
| 2015-09-30 | 2015-11-10 | $429000 | -$0.47 | -$0.38 | -23.68% |
| 2015-06-30 | 2015-08-10 | $459000 | -$0.45 | -$0.33 | -36.36% |
| 2015-03-31 | 2015-05-15 | $426000 | -$0.35 | -$0.39 | 10.26% |
| 2014-12-31 | 2015-03-10 | $505000 | -$0.37 | -$0.38 | 2.63% |
| 2014-09-30 | 2014-11-12 | $143000 | -$0.48 | -$0.43 | -11.63% |
| 2014-06-30 | 2014-08-29 | $97000 | -$2.10 |
Ocular Therapeutix, Inc (OCUL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Ocular Therapeutix, Inc (OCUL) Chart:
Ocular Therapeutix, Inc (OCUL) News:
Below you will find a list of latest news for Ocular Therapeutix, Inc (OCUL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Ocular Therapeutix, Inc (OCUL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 1482.78 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0 | CALL | 0 | 0 | 290.44 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0.55 | CALL | 2 | 223 | 73.03 | TRUE | -0.15 | -0.21 |
| 2025-04-17 | 10 | 0.07 | CALL | 0 | 130 | 70.49 | FALSE | 0 | 0 |
| 2025-04-17 | 12.5 | 0.05 | CALL | 0 | 6 | 147.69 | FALSE | 0 | 0 |
| 2025-04-17 | 15 | 0 | CALL | 0 | 0 | 258.2 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0 | PUT | 0 | 0 | 428.13 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0.19 | PUT | 0 | 1 | 163.74 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0.4 | PUT | 0 | 89 | 46.72 | FALSE | 0 | 0 |
| 2025-04-17 | 10 | 1.76 | PUT | 0 | 30 | 88.67 | TRUE | 0 | 0 |
| 2025-04-17 | 12.5 | 0 | PUT | 0 | 0 | 209.69 | TRUE | 0 | 0 |
| 2025-04-17 | 15 | 0 | PUT | 0 | 0 | 328.4 | TRUE | 0 | 0 |
| 2025-05-16 | 2.5 | 0 | CALL | 0 | 0 | 405.08 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 0 | CALL | 0 | 0 | 62.16 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 0.91 | CALL | 1 | 2 | 78.15 | TRUE | 0.91 | 0 |
| 2025-05-16 | 10 | 0.15 | CALL | 0 | 3 | 81.8 | FALSE | 0 | 0 |
| 2025-05-16 | 12.5 | 0 | CALL | 0 | 0 | 106.39 | FALSE | 0 | 0 |
| 2025-05-16 | 15 | 0 | CALL | 0 | 0 | 238.08 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 509.15 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 118.52 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 0.78 | PUT | 0 | 12 | 95.37 | FALSE | 0 | 0 |
| 2025-05-16 | 10 | 0 | PUT | 0 | 0 | 75.13 | TRUE | 0 | 0 |
| 2025-05-16 | 12.5 | 0 | PUT | 0 | 0 | 122.17 | TRUE | 0 | 0 |
| 2025-05-16 | 15 | 0 | PUT | 0 | 0 | 204.85 | TRUE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | CALL | 0 | 0 | 464.95 | TRUE | 0 | 0 |
| 2025-06-20 | 5 | 2.8 | CALL | 0 | 193 | 93.77 | TRUE | 0 | 0 |
| 2025-06-20 | 7.5 | 1.38 | CALL | 0 | 437 | 71.9 | TRUE | 0 | 0 |
| 2025-06-20 | 10 | 0.38 | CALL | 20 | 1580 | 72.97 | FALSE | 0.03 | 0.09 |
| 2025-06-20 | 12.5 | 0.15 | CALL | 0 | 134 | 73.72 | FALSE | 0 | 0 |
| 2025-06-20 | 15 | 0.6 | CALL | 0 | 80 | 109.18 | FALSE | 0 | 0 |
| 2025-06-20 | 17.5 | 0.13 | CALL | 0 | 2 | 198.97 | FALSE | 0 | 0 |
| 2025-06-20 | 20 | 0.02 | CALL | 0 | 105 | 138.09 | FALSE | 0 | 0 |
| 2025-06-20 | 22.5 | 0.04 | CALL | 0 | 10 | 110.49 | FALSE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | PUT | 0 | 0 | 388.44 | FALSE | 0 | 0 |
| 2025-06-20 | 5 | 0.26 | PUT | 0 | 319 | 83.32 | FALSE | 0 | 0 |
| 2025-06-20 | 7.5 | 0.77 | PUT | 0 | 569 | 45.18 | FALSE | 0 | 0 |
| 2025-06-20 | 10 | 2.3 | PUT | 0 | 6 | 73.11 | TRUE | 0 | 0 |
| 2025-06-20 | 12.5 | 5.34 | PUT | 0 | 10 | 100.87 | TRUE | 0 | 0 |
| 2025-06-20 | 15 | 0 | PUT | 0 | 0 | 137.61 | TRUE | 0 | 0 |
| 2025-06-20 | 17.5 | 0 | PUT | 0 | 0 | 173.7 | TRUE | 0 | 0 |
| 2025-06-20 | 20 | 0 | PUT | 0 | 0 | 180.61 | TRUE | 0 | 0 |
| 2025-06-20 | 22.5 | 0 | PUT | 0 | 0 | 128.13 | TRUE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | CALL | 0 | 0 | 116.52 | TRUE | 0 | 0 |
| 2025-09-19 | 5 | 2.55 | CALL | 0 | 23 | 79.21 | TRUE | 0 | 0 |
| 2025-09-19 | 7.5 | 1.75 | CALL | 0 | 26 | 44.13 | TRUE | 0 | 0 |
| 2025-09-19 | 10 | 1.4 | CALL | 0 | 100 | 61.2 | FALSE | 0 | 0 |
| 2025-09-19 | 12.5 | 0.6 | CALL | 0 | 176 | 73.93 | FALSE | 0 | 0 |
| 2025-09-19 | 15 | 0.5 | CALL | 0 | 25 | 82.17 | FALSE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | PUT | 0 | 0 | 270.48 | FALSE | 0 | 0 |
| 2025-09-19 | 5 | 0.5 | PUT | 0 | 1 | 77.42 | FALSE | 0 | 0 |
| 2025-09-19 | 7.5 | 2.05 | PUT | 0 | 55 | 47.6 | FALSE | 0 | 0 |
| 2025-09-19 | 10 | 0 | PUT | 0 | 0 | 69.75 | TRUE | 0 | 0 |
| 2025-09-19 | 12.5 | 0 | PUT | 0 | 0 | 77.28 | TRUE | 0 | 0 |
| 2025-09-19 | 15 | 0 | PUT | 0 | 0 | 78.74 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 5.1 | CALL | 0 | 23 | 93.94 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 6.5 | CALL | 0 | 5 | 91.94 | TRUE | 0 | 0 |
| 2026-01-16 | 3.5 | 3.8 | CALL | 0 | 62 | 77.23 | TRUE | 0 | 0 |
| 2026-01-16 | 4 | 4.08 | CALL | 0 | 48 | 121.16 | TRUE | 0 | 0 |
| 2026-01-16 | 4.5 | 4 | CALL | 0 | 29 | 94.98 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 3.1 | CALL | 0 | 57 | 87.56 | TRUE | 0 | 0 |
| 2026-01-16 | 5.5 | 3.23 | CALL | 0 | 80 | 79.07 | TRUE | 0 | 0 |
| 2026-01-16 | 7 | 2.66 | CALL | 0 | 2228 | 85.74 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 1.55 | CALL | 7 | 1752 | 81.76 | FALSE | 1.55 | 0 |
| 2026-01-16 | 12.5 | 1.15 | CALL | 0 | 6381 | 82.75 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0.8 | CALL | 0 | 2633 | 82.36 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 0.54 | CALL | 1 | 59 | 81.29 | FALSE | 0.54 | 0 |
| 2026-01-16 | 20 | 0.47 | CALL | 0 | 4912 | 72.25 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 0.45 | CALL | 0 | 35 | 89.21 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0.26 | PUT | 0 | 12 | 216.69 | FALSE | 0 | 0 |
| 2026-01-16 | 3 | 0 | PUT | 0 | 0 | 109.77 | FALSE | 0 | 0 |
| 2026-01-16 | 3.5 | 0 | PUT | 0 | 0 | 97.06 | FALSE | 0 | 0 |
| 2026-01-16 | 4 | 0 | PUT | 0 | 0 | 92 | FALSE | 0 | 0 |
| 2026-01-16 | 4.5 | 0 | PUT | 0 | 0 | 86.61 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.95 | PUT | 0 | 10 | 81.03 | FALSE | 0 | 0 |
| 2026-01-16 | 5.5 | 0 | PUT | 0 | 0 | 102.87 | FALSE | 0 | 0 |
| 2026-01-16 | 7 | 1.55 | PUT | 0 | 532 | 79.09 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 3.45 | PUT | 0 | 864 | 81.93 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 5.2 | PUT | 0 | 482 | 78.36 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 7.3 | PUT | 0 | 11 | 79.21 | TRUE | 0 | 0 |
| 2026-01-16 | 17.5 | 11.5 | PUT | 0 | 60 | 75.81 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 0 | PUT | 0 | 0 | 99.52 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | PUT | 0 | 0 | 95.97 | TRUE | 0 | 0 |
Latest OCUL Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $3.57 |
| Jun 13, 2022 7:59 PM EST | 18 | $3.565 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.57 |
| Jun 13, 2022 7:59 PM EST | 5 | $3.565 |
| Jun 13, 2022 7:59 PM EST | 2 | $3.565 |
Ocular Therapeutix, Inc (OCUL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm |
| 2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1393434/000000000019001625/0000000000-19-001625-index.htm |
| 2019-04-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1393434/000000000019006740/0000000000-19-006740-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000005341719000053/0000053417-19-000053-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000021545719006851/0000215457-19-006851-index.htm |
| 2018-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000031506618002543/0000315066-18-002543-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000031506619001221/0000315066-19-001221-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000083423720006050/0000834237-20-006050-index.htm |
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000083423720009555/0000834237-20-009555-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000089383819000008/0000893838-19-000008-index.htm |
| 2019-03-04 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1393434/000089383819000010/0000893838-19-000010-index.htm |
| 2019-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1393434/000089383819000011/0000893838-19-000011-index.htm |
| 2019-05-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000090514819000611/0000905148-19-000611-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000090514820000304/0000905148-20-000304-index.htm |
| 2018-12-28 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1393434/000104746918007791/0001047469-18-007791-index.htm |
| 2019-04-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1393434/000104746919001837/0001047469-19-001837-index.htm |
| 2019-04-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1393434/000104746919002010/0001047469-19-002010-index.htm |
| 2019-04-30 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1393434/000104746919002765/0001047469-19-002765-index.htm |
| 2020-05-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1393434/000104746920003131/0001047469-20-003131-index.htm |
| 2020-05-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1393434/000104746920003152/0001047469-20-003152-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465918066652/0001104659-18-066652-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm |
| 2018-12-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465918075138/0001104659-18-075138-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000887/0001104659-19-000887-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000889/0001104659-19-000889-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000890/0001104659-19-000890-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000891/0001104659-19-000891-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000892/0001104659-19-000892-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919000894/0001104659-19-000894-index.htm |
| 2019-01-16 | DEL AM | Delaying amendment | https://www.sec.gov/Archives/edgar/data/1393434/000110465919002007/0001104659-19-002007-index.htm |
| 2019-02-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1393434/000110465919006823/0001104659-19-006823-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919009429/0001104659-19-009429-index.htm |
| 2019-02-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919009989/0001104659-19-009989-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919013380/0001104659-19-013380-index.htm |
| 2019-03-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1393434/000110465919013389/0001104659-19-013389-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm |
| 2019-03-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919016897/0001104659-19-016897-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919016898/0001104659-19-016898-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919016981/0001104659-19-016981-index.htm |
| 2019-04-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919020175/0001104659-19-020175-index.htm |
| 2019-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919023120/0001104659-19-023120-index.htm |
| 2019-04-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1393434/000110465919023739/0001104659-19-023739-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919024896/0001104659-19-024896-index.htm |
| 2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919028431/0001104659-19-028431-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919029753/0001104659-19-029753-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919030555/0001104659-19-030555-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919032737/0001104659-19-032737-index.htm |
| 2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919033292/0001104659-19-033292-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034285/0001104659-19-034285-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm |
| 2019-06-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035409/0001104659-19-035409-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035410/0001104659-19-035410-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035411/0001104659-19-035411-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035412/0001104659-19-035412-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035413/0001104659-19-035413-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035414/0001104659-19-035414-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919035515/0001104659-19-035515-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919036832/0001104659-19-036832-index.htm |
| 2019-07-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919039304/0001104659-19-039304-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465919039308/0001104659-19-039308-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919044532/0001104659-19-044532-index.htm |
| 2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919051114/0001104659-19-051114-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919061710/0001104659-19-061710-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465919062030/0001104659-19-062030-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920009939/0001104659-20-009939-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920009941/0001104659-20-009941-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920009943/0001104659-20-009943-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920009945/0001104659-20-009945-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920012235/0001104659-20-012235-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000110465920021085/0001104659-20-021085-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920028268/0001104659-20-028268-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920032464/0001104659-20-032464-index.htm |
| 2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1393434/000110465920032495/0001104659-20-032495-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920045708/0001104659-20-045708-index.htm |
| 2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920051935/0001104659-20-051935-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920058381/0001104659-20-058381-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920061664/0001104659-20-061664-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920065123/0001104659-20-065123-index.htm |
| 2020-06-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1393434/000110465920073398/0001104659-20-073398-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077440/0001104659-20-077440-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077441/0001104659-20-077441-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077444/0001104659-20-077444-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077446/0001104659-20-077446-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077448/0001104659-20-077448-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920077449/0001104659-20-077449-index.htm |
| 2020-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920080918/0001104659-20-080918-index.htm |
| 2020-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920083953/0001104659-20-083953-index.htm |
| 2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920084290/0001104659-20-084290-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920091724/0001104659-20-091724-index.htm |
| 2020-09-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920108898/0001104659-20-108898-index.htm |
| 2020-10-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000110465920112646/0001104659-20-112646-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920112885/0001104659-20-112885-index.htm |
| 2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920114553/0001104659-20-114553-index.htm |
| 2020-10-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1393434/000110465920114581/0001104659-20-114581-index.htm |
| 2020-10-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1393434/000110465920114906/0001104659-20-114906-index.htm |
| 2020-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920115475/0001104659-20-115475-index.htm |
| 2020-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920119750/0001104659-20-119750-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000110465920121801/0001104659-20-121801-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000113777419000037/0001137774-19-000037-index.htm |
| 2020-03-25 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1393434/000114036120006856/0001140361-20-006856-index.htm |
| 2020-05-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1393434/000114036120012177/0001140361-20-012177-index.htm |
| 2019-03-18 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1393434/000139343419000001/0001393434-19-000001-index.htm |
| 2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1393434/000141057818000569/0001410578-18-000569-index.htm |
| 2019-05-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000149315219006391/0001493152-19-006391-index.htm |
| 2019-12-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000149315219019793/0001493152-19-019793-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm |
| 2020-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000453/0001493152-20-000453-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000149315220005795/0001493152-20-005795-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837018008793/0001558370-18-008793-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1393434/000155837019001659/0001558370-19-001659-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1393434/000155837019003296/0001558370-19-003296-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1393434/000155837019003299/0001558370-19-003299-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837019004776/0001558370-19-004776-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837019007462/0001558370-19-007462-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837019010684/0001558370-19-010684-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1393434/000155837020002537/0001558370-20-002537-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1393434/000155837020004640/0001558370-20-004640-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1393434/000155837020004644/0001558370-20-004644-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837020005871/0001558370-20-005871-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837020009817/0001558370-20-009817-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1393434/000155837020012870/0001558370-20-012870-index.htm |
| 2019-03-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761919006040/0001567619-19-006040-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm |
| 2019-02-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1393434/999999999519000194/9999999995-19-000194-index.htm |
| 2019-04-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1393434/999999999519000902/9999999995-19-000902-index.htm |
| 2019-10-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1393434/999999999719007342/9999999997-19-007342-index.htm |
Ocular Therapeutix, Inc (OCUL) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc (OCUL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 466%Institutional Ownership: 5542%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-10 | Kevin F. Hanley | Officer | Buy | 10,000.00 | 5.60 | 56,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm |
| 2019-03-13 | RICHARD L MD LINDSTROM | Director | Buy | 56,441.00 | 4.33 | 244,389.53 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm |
| 2019-06-07 | Amarpreet Sawhney | Chairman of the Board | Buy | 65,468.00 | 3.02 | 197,713.36 | 1,056,031.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm |
| 2019-03-15 | Michael H. Goldstein | Chief Medical Officer | Buy | 10,000.00 | 4.15 | 41,500.00 | 13,686.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm |
| 2018-12-14 | Kevin F. Hanley | Officer | Buy | 10,000.00 | 5.50 | 55,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm |
| 2019-12-30 | Opaleye Management Inc. | 10% Share Holder | Buy | 5,000.00 | 3.97 | 19,852.50 | 207,500.00 | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm |
| 2019-03-15 | Jeffrey S. Heier | Director | Buy | 24,000.00 | 4.15 | 99,600.00 | 24,000.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm |
| 2019-06-14 | Donald Notman | Chief Financial Officer | Buy | 2,500.00 | 4.33 | 10,825.00 | 24,049.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm |
| 2019-05-28 | Michael H. Goldstein | Chief Medical Officer | Buy | 12,000.00 | 2.51 | 30,120.00 | 25,686.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm |
| 2020-03-13 | SUMMER ROAD LLC | 10% Share Holder | Buy | 210,800.00 | 4.63 | 975,982.92 | 4,015,588.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm |
| 2020-03-16 | SUMMER ROAD LLC | 10% Share Holder | Buy | 194,262.00 | 4.16 | 807,216.89 | 4,209,850.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm |
| 2018-12-06 | Daniel M Bollag | Officer | Buy | 17,400.00 | 5.76 | 100,224.00 | 42,100.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm |
| 2019-06-14 | Leslie J. Williams | Director | Buy | 4,500.00 | 4.40 | 19,800.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm |
| 2020-03-17 | SUMMER ROAD LLC | 10% Share Holder | Buy | 550,000.00 | 4.66 | 2,562,890.00 | 4,759,850.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm |
| 2019-12-30 | Opaleye Management Inc. | 10% Share Holder | Buy | 15,000.00 | 3.97 | 59,557.50 | 4,903,500.00 | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm |
| 2020-01-02 | Opaleye Management Inc. | 10% Share Holder | Buy | 15,000.00 | 3.90 | 58,507.50 | 4,918,500.00 | https://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm |
| 2020-03-18 | SUMMER ROAD LLC | 10% Share Holder | Buy | 344,938.00 | 4.62 | 1,594,199.95 | 5,104,788.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm |
| 2020-03-19 | SUMMER ROAD LLC | 10% Share Holder | Buy | 40,900.00 | 4.63 | 189,223.85 | 5,145,688.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm |
| 2020-03-20 | SUMMER ROAD LLC | 10% Share Holder | Buy | 9,100.00 | 4.52 | 41,119.26 | 5,154,788.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm |
| 2020-03-23 | SUMMER ROAD LLC | 10% Share Holder | Buy | 64,948.00 | 4.66 | 302,365.41 | 5,219,736.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm |
| 2020-03-24 | SUMMER ROAD LLC | 10% Share Holder | Buy | 35,052.00 | 4.87 | 170,713.76 | 5,254,788.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm |
| 2020-05-19 | SUMMER ROAD LLC | 10% Share Holder | Buy | 363,636.00 | 5.50 | 1,999,998.00 | 5,618,424.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm |
| 2020-10-16 | SUMMER ROAD LLC | 10% Share Holder | Buy | 437.00 | 10.48 | 4,579.76 | 5,618,861.00 | https://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm |
| 2019-06-04 | Amarpreet Sawhney | Chairman of the Board | Buy | 12,928.00 | 2.92 | 37,749.76 | 898,711.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm |
| 2019-06-05 | Amarpreet Sawhney | Chairman of the Board | Buy | 32,852.00 | 2.91 | 95,599.32 | 931,563.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm |
| 2019-06-06 | Antony C. Mattessich | President & CEO | Buy | 40,000.00 | 2.81 | 112,400.00 | 97,900.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm |
| 2019-06-06 | Amarpreet Sawhney | Chairman of the Board | Buy | 59,000.00 | 2.80 | 165,200.00 | 990,563.00 | https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm |